GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (CHIX:GNSl) » Definitions » Net Cash per Share

Genus (CHIX:GNSL) Net Cash per Share : £-6.75 (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genus Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Genus's Net Cash per Share for the quarter that ended in Jun. 2024 was £-6.75.

The historical rank and industry rank for Genus's Net Cash per Share or its related term are showing as below:

CHIX:GNSl's Price-to-Net-Cash is not ranked *
in the Biotechnology industry.
Industry Median: 4.215
* Ranked among companies with meaningful Price-to-Net-Cash only.

Genus Net Cash per Share Historical Data

The historical data trend for Genus's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Net Cash per Share Chart

Genus Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.98 -4.74 -6.21 -6.13 -6.75

Genus Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.21 -6.26 -6.13 -6.75 -6.75

Competitive Comparison of Genus's Net Cash per Share

For the Biotechnology subindustry, Genus's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genus's Price-to-Net-Cash Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Genus's Price-to-Net-Cash falls into.



Genus Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Genus's Net Cash per Share for the fiscal year that ended in Jun. 2024 is calculated as

Net Cash per Share (A: Jun. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(42.5-485-1.2)/65.6881
=-6.75

Genus's Net Cash per Share for the quarter that ended in Jun. 2024 is calculated as

Net Cash per Share (Q: Jun. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(42.5-485-1.2)/65.6881
=-6.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genus  (CHIX:GNSl) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Genus Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Genus's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Genus Business Description

Traded in Other Exchanges
Address
Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus Headlines

No Headlines